Cryo-EM structure of Mycobacterium tuberculosis 50S ribosomal subunit bound with clarithromycin reveals dynamic and specific interactions with macrolides

References

• WHO. Global tuberculosis report. 2021. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2021.
   Google Scholar
• Wilson DN. Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nat Rev Microbiol. 2014;12(1):35–48.
   PubMed Web of Science ®Google Scholar
• Adeniji AA, Knoll KE, Loots DT. Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus. Appl Microbiol Biotechnol. 2020;104(13):5633–5662.
   PubMed Web of Science ®Google Scholar
• Van der Paardt AL, et al. Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis. Eur Respir J. 2017;49(3).
   PubMed Web of Science ®Google Scholar
• Sun F, et al. Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study. Eur Respir J. 2019;53(3).
   Web of Science ®Google Scholar
• Daley CL, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clin Infect Dis. 2020;71(4):e1–e36.
   PubMed Web of Science ®Google Scholar
• Fernandes PB, et al. In vitro and in vivo activities of clarithromycin against mycobacterium avium. Antimicrob Agents Chemother. 1989;33(9):1531–1534.
   PubMed Web of Science ®Google Scholar
• Dubois J, St-Pierre C. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against legionella species. Diagn Microbiol Infect Dis. 1999;33(4):261–265.
   PubMed Web of Science ®Google Scholar
• Morimoto S, et al. Chemical modification of erythromycins. II. Synthesis and antibacterial activity of O-alkyl derivatives of erythromycin A. J Antibiot (Tokyo). 1990;43(3):286–294.
   PubMed Web of Science ®Google Scholar
• Zhu ZHJ, et al. Structure-activity relationships of macrolides against mycobacterium tuberculosis. Tuberculosis. 2008;88:S49–S63.
   PubMed Web of Science ®Google Scholar
• Falzari K, et al. In vitro and in vivo activities of macrolide derivatives against mycobacterium tuberculosis. Antimicrob Agents Chemother. 2005;49(4):1447–1454.
   PubMed Web of Science ®Google Scholar
• Eyal Z, et al. Structural insights into species-specific features of the ribosome from the pathogen staphylococcus aureus. Proc Natl Acad Sci U S A. 2015;112(43):E5805–E5814.
   PubMed Web of Science ®Google Scholar
• Kannan K, Mankin AS. Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action. Ann N Y Acad Sci. 2011;1241:33–47.
   PubMed Web of Science ®Google Scholar
• Bulkley D, et al. Revisiting the structures of several antibiotics bound to the bacterial ribosome. Proc Natl Acad Sci U S A. 2010;107(40):17158–17163.
   PubMed Web of Science ®Google Scholar
• Schlunzen F, et al. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature. 2001;413(6858):814–821.
   PubMed Web of Science ®Google Scholar
• Dunkle JA, et al. Structures of the escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action. Proc Natl Acad Sci U S A. 2010;107(40):17152–17157.
   PubMed Web of Science ®Google Scholar
• Wilson DN, et al. Species-specific antibiotic-ribosome interactions: implications for drug development. Biol Chem. 2005;386(12):1239–1252.
   PubMed Web of Science ®Google Scholar
• Douthwaite S. Designer drugs for discerning bugs. Proc Natl Acad Sci U S A. 2010;107(40):17065–17066.
   PubMed Web of Science ®Google Scholar
• Kannan K, Vazquez-Laslop N, Mankin AS. Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel. Cell. 2012;151(3):508–520.
   PubMed Web of Science ®Google Scholar
• Hentschel J, et al. The complete structure of the mycobacterium smegmatis 70S ribosome. Cell Rep. 2017;20(1):149–160.
   PubMed Web of Science ®Google Scholar
• Yang K, et al. Structural insights into species-specific features of the ribosome from the human pathogen Mycobacterium tuberculosis. Nucleic Acids Res. 2017;45(18):10884–10894.
   PubMed Web of Science ®Google Scholar
• Li Z, et al. Cryo-EM structure of mycobacterium smegmatis ribosome reveals two unidentified ribosomal proteins close to the functional centers. Protein Cell. 2018;9(4):384–388.
   PubMed Web of Science ®Google Scholar
• Mishra S, et al. Structures of mycobacterium smegmatis 70S ribosomes in complex with HPF, tmRNA, and P-tRNA. Sci Rep. 2018;8(1):13587.
   PubMed Web of Science ®Google Scholar
• Halfon Y, et al. Exit tunnel modulation as resistance mechanism of S. aureus erythromycin resistant mutant. Sci Rep. 2019;9(1):11460.
   PubMed Web of Science ®Google Scholar
• Svetlov MS, et al. High-resolution crystal structures of ribosome-bound chloramphenicol and erythromycin provide the ultimate basis for their competition. Rna. 2019;25(5):600–606.
   PubMed Web of Science ®Google Scholar
• Wang L, et al. Allosteric control of the ribosome by small-molecule antibiotics. Nat Struct Mol Biol. 2012;19(9):957–963.
   PubMed Web of Science ®Google Scholar
• Li X, et al. Electron counting and beam-induced motion correction enable near-atomic-resolution single-particle cryo-EM. Nat Methods. 2013;10(6):584–590.
   PubMed Web of Science ®Google Scholar
• Mindell JA, Grigorieff N. Accurate determination of local defocus and specimen tilt in electron microscopy. J Struct Biol. 2003;142(3):334–347.
   PubMed Web of Science ®Google Scholar
• Scheres SH. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J Struct Biol. 2012;180(3):519–530.
   PubMed Web of Science ®Google Scholar
• Emsley P, et al. Features and development of coot. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 4):486–501.
   PubMed Web of Science ®Google Scholar
• Adams PD, et al. PHENIX: a comprehensive python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010;66:213–221.
   PubMed Web of Science ®Google Scholar
• Chen VB, et al. Molprobity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 1):12–21.
   PubMed Web of Science ®Google Scholar
• Morimoto S, et al. Chemical modification of erythromycins. V. Synthesis and antibacterial activity of 4''-O-methyl derivatives of erythromycin a 11,12-cyclic carbonate. J Antibiot (Tokyo). 1990;43(5):566–569.
   PubMed Web of Science ®Google Scholar
• Svetlov MS, et al. Structure of Erm-modified 70S ribosome reveals the mechanism of macrolide resistance. Nat Chem Biol. 2021;17(4):412–420.
   PubMed Web of Science ®Google Scholar
• Westhof E, Fritsch V. RNA folding: beyond watson-Crick pairs. Structure. 2000;8(3):R55–R65.
   PubMed Web of Science ®Google Scholar
• Kalra K, et al. Occurrence and stability of lone pair-π and OH-π interactions between water and nucleobases in functional RNAs. Nucleic Acids Res. 2020;48(11):5825–5838.
   PubMed Web of Science ®Google Scholar
• Kawai S, et al. Direct quantitative measurement of the C═O⋅⋅⋅H-C bond by atomic force microscopy. Sci Adv. 2017;3(5):e1603258.
   PubMed Web of Science ®Google Scholar
• Mougari F, et al. Selection of resistance to clarithromycin in Mycobacterium abscessus subspecies. Antimicrob Agents Chemother. 2017;61(1).
   PubMed Web of Science ®Google Scholar
• Furneri PM, et al. Two new point mutations at A2062 associated with resistance to 16-membered macrolide antibiotics in mutant strains of mycoplasma hominis. Antimicrob Agents Chemother. 2001;45(10):2958–2960.
   PubMed Web of Science ®Google Scholar
• Vázquez-Laslop N, et al. The key function of a conserved and modified rRNA residue in the ribosomal response to the nascent peptide. Embo J. 2010;29(18):3108–3117.
   PubMed Web of Science ®Google Scholar
• Ramu H, et al. Nascent peptide in the ribosome exit tunnel affects functional properties of the A-site of the peptidyl transferase center. Mol Cell. 2011;41(3):321–330.
   PubMed Web of Science ®Google Scholar
• Sothiselvam S, et al. Macrolide antibiotics allosterically predispose the ribosome for translation arrest. Proc Natl Acad Sci U S A. 2014;111(27):9804–9809.
   PubMed Web of Science ®Google Scholar
• Nguyen HL, et al. Erythromycin, Cethromycin and Solithromycin display similar binding affinities to the E. coli's ribosome: A molecular simulation study. J Mol Graph Model. 2019;91:80–90.
   PubMed Web of Science ®Google Scholar
• Beckert B, et al. Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics. Nat Commun. 2021;12(1):4466.
   PubMed Web of Science ®Google Scholar
• Vázquez-Laslop N, Mankin AS. How macrolide antibiotics work. Trends Biochem Sci. 2018;43(9):668–684.
   PubMed Web of Science ®Google Scholar
• Kannan K, Vázquez-Laslop N, Mankin AS. Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel. Cell. 2012;151(3):508–520.
   PubMed Web of Science ®Google Scholar
• Lin J, et al. Ribosome-Targeting antibiotics: modes of action, mechanisms of resistance, and implications for drug design. Annu Rev Biochem. 2018;87:451–478.
   PubMed Web of Science ®Google Scholar
• Fernández IS, et al. Unusual base pairing during the decoding of a stop codon by the ribosome. Nature. 2013;500(7460):107–110.
   PubMed Web of Science ®Google Scholar